Insider trades
Michael Benkowitz, COO of United Therapeutics UTHR, has filed 0 purchases and 484 sales on the open market. Over the past 12 months that comes to a net sale of $217.5M. The latest trade was on 05/13.
Michael Benkowitz
President and COO
- Company
- United Therapeutics UTHR
- First filing
- 23/01/03
- Trades
- 705 trades
- Buys / sales
- 0 / 484
- 12-month net buying
- −$217.5M
- Last trade
- 05/13
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 02/23 | 02/24 | 14,440 sh2 trades | $472.13avg. | $6,817,557.2 | −100.0% | |
| Open-market sale10b5-1 plan | 02/17 | 02/18 | 22,500 sh2 trades | $480.75avg. | $10,816,875 | −100.0% | |
| Open-market sale10b5-1 plan | 02/09 | 02/10 | 22,500 sh2 trades | $474.65avg. | $10,679,625 | −100.0% | |
| Open-market sale10b5-1 plan | 02/02 | 02/03 | 22,500 sh2 trades | $470.95avg. | $10,596,375 | −100.0% | |
| Open-market sale10b5-1 plan | 01/20–01/26 | 01/28 | 45,000 sh30 trades | $468.28avg. | $21,072,814.38 | −100.0% | |
| Open-market sale10b5-1 plan | 01/12 | 01/13 | 22,500 sh2 trades | $479.51avg. | $10,788,975 | −100.0% | |
| Open-market sale10b5-1 plan | 01/05 | 01/07 | 22,500 sh28 trades | $487.38avg. | $10,965,941.91 | −100.0% | |
| Open-market sale10b5-1 plan | 25/12/29 | 25/12/30 | 22,500 sh2 trades | $502.79avg. | $11,312,775 | −100.0% | |
| Open-market sale10b5-1 plan | 25/12/22 | 25/12/29 | 22,500 sh14 trades | $514.36avg. | $11,573,025.93 | −100.0% | |
| Open-market sale10b5-1 plan | 25/12/15 | 25/12/16 | 22,500 sh20 trades | $496.30avg. | $11,166,728.63 | −100.0% | |
| Open-market sale10b5-1 plan | 25/12/08 | 25/12/09 | 22,500 sh2 trades | $478.58avg. | $10,768,050 | −100.0% | |
| Open-market sale10b5-1 plan | 25/12/01 | 25/12/02 | 22,500 sh14 trades | $479.92avg. | $10,798,101.64 | −100.0% | |
| Open-market sale10b5-1 plan | 25/11/24 | 25/11/26 | 22,500 sh3 trades | $473.66avg. | $10,657,350 | −100.0% | |
| Open-market sale10b5-1 plan | 25/11/17 | 25/11/18 | 22,500 sh2 trades | $470.43avg. | $10,584,675 | −100.0% | |
| Open-market sale10b5-1 plan | 25/11/10 | 25/11/12 | 22,500 sh2 trades | $452.07avg. | $10,171,631.25 | −100.0% | |
| Open-market sale10b5-1 plan | 25/11/03 | 25/11/04 | 22,500 sh11 trades | $429.25avg. | $9,658,112.47 | −100.0% | |
| Open-market sale10b5-1 plan | 25/10/27 | 25/10/28 | 22,500 sh2 trades | $417.50avg. | $9,393,750 | −99.4% | |
| Open-market sale10b5-1 plan | 25/10/20 | 25/10/21 | 22,500 sh2 trades | $427.41avg. | $9,616,725 | −100.0% | |
| Open-market sale10b5-1 plan | 25/10/13 | 25/10/15 | 22,500 sh2 trades | $440.35avg. | $9,907,875 | −100.0% | |
| Open-market sale10b5-1 plan | 25/10/06 | 25/10/07 | 22,500 sh10 trades | $450.24avg. | $10,130,506.75 | −100.0% |